Ayurveda 2047: India Charts Global Blueprint to Transform Traditional Healing into Mainstream Healthcare

• Ayush exports rose from $1.09 billion (2014) to $2.16 billion (2023).

• Ayurveda products now reach around 150 countries.

• India has over 355,000 practitioners, but 95% remain domestically based.

• Roadmap proposes global registry, licensing reforms and WHO-backed research.

• Focus shifts from herb exports to high-value formulations and medical travel.

India has unveiled an ambitious long-term strategy to position Ayurveda as a globally recognised healthcare system by 2047, seeking to move it beyond its current perception as primarily a wellness or alternative therapy product.

The roadmap, titled Strategic Roadmap for Making Ayurveda Global, was released by NITI Aayog leadership alongside senior officials from the health and Ayush ministries. It lays out a multi-decade plan to strengthen regulation, research, manufacturing and global outreach so that Ayurveda can gain acceptance as a mainstream system of medicine rather than remain confined to the dietary supplement category in many developed markets.

Rising Exports, Persistent Barriers

The report highlights the steady growth of Ayush exports over the past decade. Shipments of Ayush and herbal products nearly doubled from $1.09 billion in 2014 to $2.16 billion in 2023. Today, Ayurvedic products are sold in about 150 countries.

Despite this expansion, the sector faces structural hurdles. In many advanced markets, Ayurvedic formulations are marketed as dietary supplements rather than approved medicinal products, limiting their integration into national healthcare systems. Regulatory frameworks abroad often restrict their classification, posing challenges for broader clinical acceptance.

Globally, Ayurveda has achieved varying levels of recognition in nearly 30 countries, and research initiatives related to the discipline are underway in close to 70 nations. However, India has not yet succeeded in building a substantial overseas practitioner base.

Practitioner Mobility and Licensing Gaps

India currently has more than 355,000 trained Ayurveda professionals. Yet nearly 95% of them practice within the country, largely due to the absence of internationally standardised licensing systems and limited professional mobility.

To address this constraint, the roadmap proposes establishing a Global Ayurveda Register that would maintain verifiable international credentials for practitioners. It also recommends creating a single-window digital portal detailing country-specific licensing rules and visa requirements, enabling smoother overseas placements.

Another key suggestion involves negotiating mutual recognition agreements with partner nations, allowing qualified Indian Ayurveda professionals to practice abroad under recognised standards.

Building Scientific Credibility

Improving global trust in Ayurveda will require stronger scientific validation, the report argues. It calls for expanding international clinical trials through World Health Organization (WHO) collaborating centres and developing large-scale real-world patient registries to document treatment outcomes.

The roadmap also recommends publishing annual global safety and evidence reports, promoting advanced research areas such as Ayurgenomics, and modernising domestic manufacturing to comply fully with WHO-GMP standards. An export-focused edition of the Ayurvedic Pharmacopoeia aligned with global regulatory benchmarks is also proposed to strengthen credibility in international markets.

From Raw Herbs to High-Value Healthcare

A major strategic shift outlined in the report involves moving beyond the export of raw herbs toward higher-value formulations, specialised healthcare services and medical expertise.

Recommendations include setting up overseas Ayurveda centres, strengthening exporter support through the Ayush Export Promotion Council, and launching a real-time trade monitoring dashboard. The roadmap also envisions treatment hubs linked to Ayush visas, combined with insurance-backed medical value travel to attract international patients seeking integrative healthcare solutions.

By linking Ayurveda to medical tourism and structured healthcare delivery, policymakers aim to reposition it as a comprehensive treatment system rather than a complementary wellness product.

Lessons from Traditional Chinese Medicine

Drawing parallels with the global expansion of Traditional Chinese Medicine (TCM), the report underscores the need for coordinated action across research, regulation, education, diplomacy and trade. It advocates establishing a high-level Mission Steering Group to oversee implementation of the strategy through 2047.

The approach recognises that global acceptance will depend not only on product exports but also on regulatory alignment, scientific validation, practitioner mobility and sustained diplomatic engagement.

The Long-Term Vision

The roadmap reflects a broader ambition: transforming Ayurveda into a globally trusted healthcare framework backed by evidence, regulation and international standards. While export growth signals rising global interest, achieving full integration into mainstream healthcare systems will require overcoming regulatory barriers, strengthening scientific foundations and enhancing professional recognition.

If implemented effectively, the 2047 vision could redefine Ayurveda’s role—from a niche wellness offering to a structured, globally accepted system of medicine rooted in India’s traditional knowledge but aligned with modern healthcare norms.